Some leading companies in the Companion Diagnostics (CDx) sector in Japan include Roche Diagnostics, Myriad Genetics, Foundation Medicine, and Sysmex Corporation. These companies play a significant role in advancing personalized medicine in Japan, particularly through the development and provision of innovative CDx tests, frequently for oncology applications.
